TOKYO, Dec 14 (Reuters) - Japanese shares edged higher on
Monday as progress on COVID-19 vaccine roll-outs globally lifted
risk sentiment, while a Bank of Japan survey showed business
sentiment improved at the fastest pace in nearly two decades in
October-December.
The Nikkei share average .N225 rose 0.64% to 26,823.25 by
the midday break, rebounding from its first weekly loss in six.
The broader Topix .TOPX gained 1.22% to 1,803.73, its highest
since October 2018.
All but one of the 33 sector sub-indexes on the Tokyo
exchange traded higher.
The market tracked U.S. stock futures higher in the morning
session on growing hopes of a swift global economic recovery
amid progress on coronavirus vaccines, with the first shipments
speeding across the United States. The Bank of Japan's tankan survey also supported market
sentiment, as the mood among big manufacturers improved for the
second straight quarter to minus 10 this month from minus 27 in
September. But investors remained cautious over rising coronavirus
cases. Japan reported a record of more than 3,000 new daily
infections on Saturday and the capital Tokyo confirmed 621 new
cases.
Japanese Prime Minister Yoshihide Suga will chair a
coronavirus meeting later in the day and could further restrict
a travel subsidy programme to contain mounting infections.
Toyota Motor 7203.T rose more than 2.1% to hit its highest
level since early February, supported by the announcement of a
revamped hydrogen fuel cell car as well as by solid November
Chinese auto sales data. Nintendo 7974.T jumped 3.41% as the Kyoto-based gaming
company continued to benefit from tougher social restrictions.
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Japan shares edge higher on vaccine roll-out progress, BOJ tankan
Published 14/12/2020, 04:21
Japan shares edge higher on vaccine roll-out progress, BOJ tankan
Latest comments
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.